Table 2.
Characteristics | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | p value | 95% CI | HR | p value | 95% CI | |
Sex (female vs male) | 1.216 | 0.660 | 0.508–2.910 | |||
Age (<60 vs ≥60) | 1.831 | 0.159 | 0.789–4.251 | |||
Differentiation (well+moderate vs poor) | 1.633 | 0.253 | 0.705–3.785 | |||
Tumor Size (<5 vs ≥5 cm) | 2.350 | 0.048 | 1.008–5.480 | 2.068 | 0.138 | 0.792–5.400 |
TNM stage (I, II vs III, IV) | 5.280 | 0.003 | 1.770–15.748 | 4.434 | 0.008 | 1.463–13.435 |
Nerves (negative vs positive) | 2.223 | 0.152 | 0.745–6.629 | |||
Vessels (negative vs positive) | 0.975 | 0.956 | 0.396–2.400 | |||
Lymph node (N0-1 vs N2-3) | 1.559 | 0.334 | 0.633–3.840 | |||
Tumor site (Antrum vs Cardia) | 1.127 | 0.686 | 0.632–2.010 | |||
miR-140-3p level (high vs low) | 2.571 | 0.052 | 0.992–6.664 | |||
BCL2 level (low vs high) | 3.159 | 0.013 | 1.271–7.852 | 2.402 | 0.062 | 0.956–6.037 |
Note: p<0.05 is indicated in bold.
Abbreviations: TNM, tumor-node-metastasis; HR, hazard ratio; CI, confidence interval; high, high expression; low, low expression.